世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ペースメーカ市場:移植毎(体外)、技術毎(単腔、二腔、両心室ペースメーカ)、タイプ毎(従来型、MRI対応)、エンドユーザ毎(病院、心疾患センタ、外来手術センタ) - 2023年までの世界市場予測

Pacemakers Market by Implantability (External), Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), Type (Conventional, MRI Compatible), End User (Hospitals and Cardiac Centers, Ambulatory Surgical Center) - Global Forecast to 2023

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2018年11月US$5,650
シングルユーザライセンス
123 138

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)のペースメーカ市場に関する調査レポートです。

“Increasing prevalence of cardiovascular diseases is expected to drive the overall growth of the pacemakers market.”

The pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0%. The pacemakers market is driven by various factors such by increasing prevalence of cardiovascular diseases and technological advancements in devices. However, the high cost of pacemakers and an unfavorable reimbursement scenario are expected to limit market growth to a certain extent.

“The dual-chamber pacemakers segment is expected to grow at a higher CAGR during the forecast period.”

The dual-chamber pacemakers are the faster-growing segment in the pacemakers market, by technology. The pacemakers market, by technology, has been categorized into single-chamber pacemakers, dual-chamber, and biventricular/CRT pacemakers. Dual-chamber pacemakers are the most popular of all pacemaker technologies in the market, due to the higher efficiency and cost-effectiveness of dual-chamber pacemakers in atrioventricular block or sick sinus syndrome.

“The hospitals & cardiac centers, by end user, is projected to hold the largest market share during the forecast period.”

This segment includes both government and private hospitals and cardiac centers that provide treatment to patients with cardiac diseases. A number of factors, such as the increasing prevalence of cardiovascular diseases and the subsequent increase in the number of surgical procedures performed, improving healthcare infrastructure, and favorable reimbursement scenario are driving the growth of the pacemakers market for hospitals & cardiac centers.

“Asia Pacific is expected to record the highest growth rate during the forecast period.”

The Asia Pacific pacemakers market, particularly in China, Japan, India, is expected to witness high growth in the next five years. This can largely be attributed to the increasing prevalence of CVDs in these countries due to various factors such as increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the pacemakers market.  

--By Company Type: Tier 1: 45%, Tier 2: 34%, and Tier 3: 21%
--By Designation: C-level Executives: 14%, Directors: 10%, and Others: 76%
--By Region: North America: 32%, Europe: 35%, APAC: 25%, and RoW: 8%  

The pacemakers market comprises major providers such Medtronic (Ireland), Abbott (US), and Boston Scientific (US), BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China). The study includes an in-depth competitive analysis of these key players in the pacemakers market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the pacemakers market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of type, technology, implantability, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market; along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall pacemakers market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and will provide them with information on key market drivers, restraints, challenges, and opportunities.



目次

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 15
1.3.2 YEARS COVERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 PRIMARY DATA 18
2.1.1.1 Key data from primary sources 19
2.1.2 SECONDARY DATA 20
2.1.2.1 Key data from secondary sources 20
2.2 MARKET ESTIMATION METHODOLOGY 21
2.2.1 PRIMARY RESEARCH VALIDATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 25
2.5 LIMITATIONS 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 29
4.1 PACEMAKERS: MARKET OVERVIEW 29
4.2 PACEMAKERS MARKET: GEOGRAPHICAL SNAPSHOT 30
4.3 PACEMAKERS MARKET, BY TECHNOLOGY (2018-2023) 31
4.4 ASIA PACIFIC: PACEMAKERS MARKET, BY TECHNOLOGY (2017) 31

5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Increasing burden of CVD 33
5.2.1.2 Technological advancements 33
5.2.2 RESTRAINTS 34
5.2.2.1 High cost of pacemakers, unfavorable reimbursement scenario 34
-
5.2.3 OPPORTUNITIES 34
5.2.3.1 Emerging markets 34
5.2.3.2 Implantable micropacemakers designed for fetal use 35
5.2.4 CHALLENGES 35
5.2.4.1 Shortage of cardiac surgeons 35
5.2.4.2 Frequent product recalls 35

6 PACEMAKERS MARKET, BY IMPLANTABILITY 37
6.1 INTRODUCTION 38
6.1.1 IMPLANTABLE PACEMAKERS 38
6.1.1.1 Introduction of leadless, miniaturized implantable pacemakers to boost segment popularity 38
6.1.2 EXTERNAL PACEMAKER 40
6.1.2.1 North America to lead the external pacemakers market during the forecast period 40

7 PACEMAKERS MARKET, BY TECHNOLOGY 43
7.1 INTRODUCTION 44
7.1.1 DUAL-CHAMBER PACEMAKERS 44
7.1.1.1 Dual-chamber pacemakers are the most popular of all pacemaker technologies in the market 44
7.1.2 SINGLE-CHAMBER PACEMAKERS 46
7.1.2.1 The advent of leadless pacemakers will stimulate demand in this product segment 46
7.1.3 BIVENTRICULAR/CRT PACEMAKERS 48
7.1.3.1 North America is the largest market for biventricular/CRT pacemakers 48

8 PACEMAKERS MARKET, BY TYPE 51
8.1 INTRODUCTION 52
8.1.1 MRI COMPATIBLE PACEMAKERS 52
8.1.1.1 Technological advancement is driving the growth of MRI Compatible pacemakers 52
8.1.2 CONVENTIONAL PACEMAKERS 54
8.1.2.1 Increasing aging population is a major factor driving the growth of the conventional pacemaker market 54

9 PACEMAKERS MARKET, BY END USER 57
9.1 INTRODUCTION 58
9.2 HOSPITALS & CARDIAC CENTERS 58
9.2.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES 58
9.3 AMBULATORY SURGICAL CENTERS 60
9.3.1 INCREASING NUMBER OF ASCS IN THE US 60
-
10 PACEMAKERS MARKET, BY REGION 63
10.1 INTRODUCTION 64
10.2 NORTH AMERICA 65
10.2.1 US 68
10.2.1.1 Rising prevalence of CVDs and technological advancements in pacemakers are the major factors driving market growth 68
10.2.2 CANADA 71
10.2.2.1 Rising prevalence of CVDs and growing geriatric population are driving the growth of the Canadian pacemakers market 71
10.3 EUROPE 73
10.3.1 GERMANY 75
10.3.1.1 Germany is expected to account for the largest share of European pacemakers market in 2018 75
10.3.2 FRANCE 77
10.3.2.1 Favorable insurance system is driving the growth of the French pacemakers market 77
10.3.3 UK 79
10.3.3.1 Technological advancements in pacemaker devices to drive the demand for pacemakers in the country 79
10.3.4 REST OF EUROPE 81
10.4 ASIA PACIFIC 83
10.4.1 JAPAN 86
10.4.1.1 MRI Compatible pacemakers have huge growth potential in Japan 86
10.4.2 CHINA 87
10.4.2.1 Increasing prevalence of CVDs is driving the growth of the pacemakers market in China 87
10.4.3 INDIA 89
10.4.3.1 Increasing pacemaker implantation procedures in India to propel market growth 89
10.4.4 REST OF ASIA PACIFIC (ROAPAC) 91
10.5 REST OF THE WORLD 93

11 COMPETITIVE LANDSCAPE 95
11.1 INTRODUCTION 95
11.2 PACEMAKERS MARKET SHARE ANALYSIS 95
11.3 COMPETITIVE SITUATION AND TRENDS 96
11.3.1 PRODUCT LAUNCHES 96
11.3.2 COLLABORATIONS 96
11.3.3 EXPANSIONS 97
11.3.4 MERGERS & ACQUISITIONS 97
-
12 COMPANY PROFILES 98
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 MEDTRONIC 98
12.2 ABBOTT LABORATORIES 101
12.3 BOSTON SCIENTIFIC 103
12.4 BIOTRONIK 106
12.5 LIVANOVA 108
12.6 LEPU MEDICAL 110
12.7 SHREE PACETRONIX 112
12.8 OSYPKA MEDICAL 113
12.9 MEDICO SPA 114
12.10 OSCOR 115

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13 APPENDIX 116
13.1 DISCUSSION GUIDE 116
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 119
13.3 AVAILABLE CUSTOMIZATIONS 121
13.4 RELATED REPORTS 121
13.5 AUTHOR DETAILS 122

 

LIST OF TABLES

TABLE 1 CONVENTIONAL VS. MRI COMPATIBLE PACEMAKERS: PRICE LIST 34
TABLE 2 LIST OF PRODUCT RECALLS 36
TABLE 3 PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 38
TABLE 4 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION) 39
TABLE 5 NORTH AMERICA: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 39
TABLE 6 EUROPE: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 39
TABLE 7 ASIA PACIFIC: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 40
TABLE 8 EXTERNAL PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION) 40
TABLE 9 NORTH AMERICA: EXTERNAL PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 41
TABLE 10 EUROPE: EXTERNAL PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 41
TABLE 11 ASIA PACIFIC: EXTERNAL PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 42
TABLE 12 PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 44
TABLE 13 DUAL-CHAMBER PACEMAKERS: KEY MANUFACTURERS AND PRODUCTS 44
TABLE 14 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION) 45
TABLE 15 NORTH AMERICA: DUAL-CHAMBER PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 45
TABLE 16 EUROPE: DUAL-CHAMBER PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 45
TABLE 17 ASIA PACIFIC: DUAL-CHAMBER PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 46
TABLE 18 SINGLE-CHAMBER PACEMAKERS: KEY MANUFACTURERS AND PRODUCTS 46
TABLE 19 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION,
2016-2023 (USD MILLION) 47
TABLE 20 NORTH AMERICA: SINGLE-CHAMBER PACEMAKERS MARKET,
BY COUNTRY, 2016-2023 (USD MILLION) 47
TABLE 21 EUROPE: SINGLE-CHAMBER PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 47
TABLE 22 ASIA PACIFIC: SINGLE-CHAMBER PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 48
TABLE 23 BIVENTRICULAR/CRT PACEMAKERS: KEY MANUFACTURERS AND PRODUCTS 48
TABLE 24 BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION) 49
TABLE 25 NORTH AMERICA: BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 49
TABLE 26 EUROPE: BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 49
TABLE 27 ASIA PACIFIC: BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 50
TABLE 28 PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 52
TABLE 29 MRI COMPATIBLE PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION) 53
TABLE 30 NORTH AMERICA: MRI COMPATIBLE PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 53
TABLE 31 EUROPE: MRI COMPATIBLE PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 53
TABLE 32 ASIA PACIFIC: MRI COMPATIBLE PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 54
TABLE 33 CONVENTIONAL PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION) 55
TABLE 34 NORTH AMERICA: CONVENTIONAL PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 55
TABLE 35 EUROPE: CONVENTIONAL PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 55
TABLE 36 ASIA PACIFIC: CONVENTIONAL PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 56
TABLE 37 PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 58
TABLE 38 PACEMAKERS MARKET FOR HOSPITALS & CARDIAC CENTERS,
BY REGION, 2016-2023 (USD MILLION) 59
TABLE 39 NORTH AMERICA: PACEMAKERS MARKET FOR HOSPITALS & CARDIAC CENTERS, BY COUNTRY, 2016-2023 (USD MILLION) 59
TABLE 40 EUROPE: PACEMAKERS MARKET FOR HOSPITALS & CARDIAC CENTERS,
BY COUNTRY, 2016-2023 (USD MILLION) 59
TABLE 41 ASIA PACIFIC: PACEMAKERS MARKET FOR HOSPITALS & CARDIAC CENTERS,
BY COUNTRY, 2016-2023 (USD MILLION) 60
TABLE 42 PACEMAKERS MARKET FOR AMBULATORY SURGICAL CENTERS,
BY REGION, 2016-2023 (USD MILLION) 61
TABLE 43 NORTH AMERICA: PACEMAKERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016-2023 (USD MILLION) 61
TABLE 44 EUROPE: PACEMAKERS MARKET FOR AMBULATORY SURGICAL CENTERS,
BY COUNTRY, 2016-2023 (USD MILLION) 61
TABLE 45 ASIA PACIFIC: PACEMAKERS MARKET FOR AMBULATORY SURGICAL CENTERS,
BY COUNTRY, 2016-2023 (USD MILLION) 62
TABLE 46 PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION) 64
TABLE 47 PACEMAKERS MARKET, BY REGION, 2016-2023 (THOUSAND UNITS) 64
TABLE 48 NORTH AMERICA: PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 66
TABLE 49 NORTH AMERICA: PACEMAKERS MARKET, BY COUNTRY,
2016-2023 (THOUSAND UNITS) 66
TABLE 50 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY,
2016-2023 (USD MILLION) 66
TABLE 51 NORTH AMERICA: PACEMAKERS MARKET, BY TECHNOLOGY,
2016-2023 (USD MILLION) 67
TABLE 52 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 67
TABLE 53 NORTH AMERICA: PACEMAKERS MARKET, BY END USER,
2016-2023 (USD MILLION) 67
TABLE 54 CLINICAL TRAILS RELATED TO PACEMAKERS IN THE US 68
TABLE 55 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 69
TABLE 56 US: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 70
TABLE 57 US: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 70
TABLE 58 US: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 70
TABLE 59 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 71
TABLE 60 CANADA: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 71
TABLE 61 CANADA: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 72
TABLE 62 CANADA: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 72
TABLE 63 EUROPE: PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 73
TABLE 64 EUROPE: PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (THOUSAND UNITS) 73
TABLE 65 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 74
TABLE 66 EUROPE: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 74
TABLE 67 EUROPE: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 74
TABLE 68 EUROPE: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 75
TABLE 69 GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY,
2016-2023 (USD MILLION) 76
TABLE 70 GERMANY: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 76
TABLE 71 GERMANY: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 77
TABLE 72 GERMANY: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 77
TABLE 73 FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 78
TABLE 74 FRANCE: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 78
TABLE 75 FRANCE: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 78
TABLE 76 FRANCE: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 79
TABLE 77 UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 79
TABLE 78 UK: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 80
TABLE 79 UK: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 80
TABLE 80 UK: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 80
TABLE 81 ROE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 81
TABLE 82 ROE: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 81
TABLE 83 ROE: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 82
TABLE 84 ROE: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 82
TABLE 85 APAC: PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 84
TABLE 86 APAC: PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (THOUSAND UNITS) 84
TABLE 87 APAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 84
TABLE 88 APAC: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 85
TABLE 89 APAC: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 85
TABLE 90 ASIA PACIFIC: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 85
TABLE 91 JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 86
TABLE 92 JAPAN: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 86
TABLE 93 JAPAN: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 87
TABLE 94 JAPAN: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 87
TABLE 95 CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 88
TABLE 96 CHINA: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 88
TABLE 97 CHINA: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 88
TABLE 98 CHINA: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 89
TABLE 99 INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 89
TABLE 100 INDIA: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 90
TABLE 101 INDIA: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 90
TABLE 102 INDIA: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 90
TABLE 103 ROAPAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 91
TABLE 104 ROAPAC: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 91
TABLE 105 ROAPAC: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 92
TABLE 106 ROAPAC: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 92
TABLE 107 ROW: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION) 93
TABLE 108 ROW: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION) 93
TABLE 109 ROW: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION) 94
TABLE 110 ROW: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION) 94
TABLE 111 PRODUCT LAUNCHES, 2015 TO 2018 96
TABLE 112 COLLABORATIONS AND AGREEMENTS 2015-2018 96
TABLE 113 EXPANSIONS, 2015 TO 2018 97
TABLE 114 MERGERS & ACQUISITIONS, 2015-2018 97

 

LIST OF FIGURES

FIGURE 1 PACEMAKERS MARKET: RESEARCH METHODOLOGY STEPS 17
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 BREAKDOWN OF PRIMARIES 19
FIGURE 4 MARKET ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 22
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 23
FIGURE 6 DATA TRIANGULATION 24
FIGURE 7 PACEMAKERS MARKET, BY IMPLANTABILITY, 2018 VS. 2023 (USD MILLION) 26
FIGURE 8 PACEMAKERS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION) 26
FIGURE 9 PACEMAKERS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION) 27
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE PACEMAKERS MARKET 28
FIGURE 11 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES-MAJOR FACTOR DRIVING MARKET GROWTH 29
FIGURE 12 US ACCOUNTED FOR THE LARGEST SHARE OF THE PACEMAKERS MARKET IN 2017 30
FIGURE 13 DUAL-CHAMBER PACEMAKERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018-2023) 31
FIGURE 14 DUAL-CHAMBER PACEMAKERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC PACEMAKERS MARKET IN 2017 31
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: PACEMAKER MARKET 32
FIGURE 16 NORTH AMERICA: PACEMAKERS MARKET SNAPSHOT 65
FIGURE 17 INCIDENCE OF CVD, IHD, AND STROKE IN GERMANY, 2015 75
FIGURE 18 ASIA PACIFIC: PACEMAKERS MARKET SNAPSHOT 83
FIGURE 19 MEDTRONIC: COMPANY SNAPSHOT (2018) 98
FIGURE 20 ABBOTT LABORATORIES : COMPANY SNAPSHOT (2017) 101
FIGURE 21 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2017) 103
FIGURE 22 LIVANOVA : COMPANY SNAPSHOT (2017) 108
FIGURE 23 LEPU MEDICAL: COMPANY SNAPSHOT (2016) 110
FIGURE 24 SHREE PACETRONIX: COMPANY SNAPSHOT (2017) 112

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

Pacemakers Market worth $4.9 billion by 2023

 

November 5, 2018

The report "Pacemakers Market by Implantability (External), Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), Type (Conventional, MRI Compatible), End User (Hospitals and Cardiac Centers, Ambulatory Surgical Center) - Global Forecast to 2023", The pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0%. Growth in this market is driven by increasing prevalence of cardiovascular diseases and technological advancements in devices.

The implantable pacemakers segment, by implantability, projected to occupy the majority of the market share and grow at the fastest rate during the forecast period.

The implantable pacemakers segment is projected to be the fastest-growing segment, by implantability, during the forecast period. The large share of the implantable pacemakers segment is primarily attributed to the increasing prevalence of CVDs and the rising preference for these pacemakers due to their benefits over their external counterparts.

The MRI compatible pacemakers segment, by livestock, is projected to occupy the majority of the market share and grow at the fastest rate during the forecast period.

The MRI compatible pacemakers segment is projected to be the fastest-growing segment, by type, during the forecast period. This can be attributed to the growing number of patients with implanted pacemakers and the increasing need for MRI scans in the geriatric population, as patients in this age group are more likely to have cardiac devices such as pacemakers.

North America is projected to account for the largest market size in the pacemakers market during the forecast period.

North America is estimated to account for the largest share of the market in 2018. Factors such as the rising prevalence of CVDs, growing geriatric population, increasing healthcare expenditure, and the availability of technologically advanced devices are driving the growth of the pacemakers market in North America.

Major vendors in the pacemakers market include Medtronic (Ireland), Abbott (US), and Boston Scientific (US), BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China).

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る